2007Journal of Jilin UniversityRequires access

Inhibitory effect of novel polyoxometalate on hepatitis B virus replication in vitro

Juan Li

Open publisher page 1 citations

Abstract

Objective To evaluate the activity of novel polyoxometalate against hepatitis B virus (HBV) in vitro.Methods MTT assay was used to evaluate the growth inhibitory effects of polyoxometalate on 2.2.15 cell lines,Hepatitis B e(s) antigen(HBeAg) and Hepatitis B surface antigen in the culture medium were determined by ELISA.Southern blotting was performed to detect HBV DNA in Hep G2 2.2.15 cells.Real-time quantity PCR was applied to detect the contents of introcellular HBV mRNA and extracellular HBV DNA.Results The median toxicity concentration(TC50) was 1590.46 mg·L-1 on 2.2.15 cells.The inhibitory rats of PTW-6 on HBeAg and HBsAg were markedly higher compared with control group(P0.05).The median inhibitory concentration(IC50) of PTE-6 in extracellular HBV DNA and introcellular HBV mRNA were 51.1 and 63.6 mg·L-1,respectively.Conclusion Novel polyoxometalate is a potential compound for treatment chronic HBV infection.

About this research paper

What this paper is about

Objective To evaluate the activity of novel polyoxometalate against hepatitis B virus (HBV) in vitro.Methods MTT assay was used to evaluate the growth inhibitory effects of polyoxometalate on 2.2.15 cell lines,Hepatitis B e(s) antigen(HBeAg) and Hepatitis B surface antigen in the culture medium were determined by ELISA.Southern blotting was performed to detect HBV DNA in Hep G2 2.2.15 cells.Real-time quantity PCR was applied to detect the contents of introcellular HBV mRNA and extracellular HBV DNA.Results The median toxicity concentration(TC50) was 1590.46 mg·L-1 on 2.2.15 cells.The inhibitory rats of PTW-6 on HBeAg and HBsAg were markedly higher compared with control group(P0.05).The median inhibitory concentration(IC50) of PTE-6 in extracellular HBV DNA and introcellular HBV mRNA were 51.1 and 63.6 mg·L-1,respectively.Conclusion Novel polyoxometalate is a potential compound for treatment chronic HBV infection.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the activity of novel polyoxometalate against hepatitis B virus (HBV) in vitro.Methods MTT assay was used to evaluate the growth inhibitory effects of polyoxometalate on 2.2.15 cell lines,Hepatitis B e(s) antigen(HBeAg) and Hepatitis B surface antigen in the culture medium were determined by ELISA.Southern blotting was performed to detect HBV DNA in Hep G2 2.2.15 cells.Real-time quantity PCR was applied to detect the contents of introcellular HBV mRNA and extracellular HBV DNA.Results The median toxicity concentration(TC50) was 1590.46 mg·L-1 on 2.2.15 cells.The inhibitory rats of PTW-6 on HBeAg and HBsAg were markedly higher compared with control group(P0.05).The median inhibitory concentration(IC50) of PTE-6 in extracellular HBV DNA and introcellular HBV mRNA were 51.1 and 63.6 mg·L-1,respectively.Conclusion Novel polyoxometalate is a potential compound for treatment chronic HBV infection.

Key concepts: HBeAg, HBsAg, Hepatitis B virus, In vitro, Virology, Molecular biology, IC50, Extracellular

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibitory effect of novel polyoxometalate on hepatitis B virus replication in vitro — Research Paper | ScholarLens